BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC) GlobeNewswire December 31, 2025 BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC […]

Highlander Silver Announces Planned NYSE American Listing in Q1/26

Highlander Silver Announces Planned NYSE American Listing in Q1/26 GlobeNewswire December 31, 2025 TORONTO, Dec. 31, 2025 (GLOBE NEWSWIRE) — Highlander Silver Corp. (TSX: HSLV; “Highlander Silver” or the “Company“) is pleased to announce plans to pursue a listing on the NYSE American LLC (“NYSE American”) as part of its U.S. growth strategy. The Company

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission

(NasdaqGM:AXSM), New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has received formal pre-New Drug Application (NDA) meeting minutes from the

YieldMax(R) ETFs Announces Weekly Distributions for Group 2 ETFs

CHICAGO and MILWAUKEE and NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — YieldMax(R) ETFs today announced distributions for the YieldMax(R) Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex. & Record Date: January 2, 2026Payment Date: January 5, 2026 ETF Ticker1 ETF Name Distribution Frequency Distribution per Share Distribution Rate2,4 30-DaySEC Yield3 ROC5 ABNY

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission GlobeNewswire December 31, 2025 New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system

YieldMax(R) ETFs Announces Weekly Distributions for Group 2 ETFs

YieldMax(R) ETFs Announces Weekly Distributions for Group 2 ETFs GlobeNewswire December 31, 2025 CHICAGO and MILWAUKEE and NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — YieldMax(R) ETFs today announced distributions for the YieldMax(R) Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex. & Record Date: January 2, 2026Payment Date: January 5, 2026 ETF Ticker1

Magna Mining Files Technical Report for the Mineral Resource Estimate on the Levack Mine Property in Sudbury

(TSX-V – NEX Board:NICU),(OTC US:MGMNF),(Other OTC:MGMNF),(Boerse Frankfurt – Freiverkehr:8YD), SUDBURY, Ontario, Dec. 31, 2025 (GLOBE NEWSWIRE) — Magna Mining Inc. (TSXV: NICU) (OTCQX: MGMNF) (FSE: 8YD) (“Magna” or the “Company”) is pleased to announce that further to its news release dated November 18, 2025 titled “Magna Mining Reports Mineral Resource Estimate for the Levack Mine

Brown & Brown, Inc. announces 2025 fourth-quarter earnings release and conference call dates

(NYSE:BRO), DAYTONA BEACH, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE: BRO) announces it will release its 2025 fourth-quarter earnings on Monday, January 26, 2026, after the close of the market. On Tuesday, January 27, 2026, J. Powell Brown, Brown & Brown's president and chief executive officer, and R. Andrew Watts,

Magna Mining Files Technical Report for the Mineral Resource Estimate on the Levack Mine Property in Sudbury

Magna Mining Files Technical Report for the Mineral Resource Estimate on the Levack Mine Property in Sudbury GlobeNewswire December 31, 2025 SUDBURY, Ontario, Dec. 31, 2025 (GLOBE NEWSWIRE) — Magna Mining Inc. (TSXV: NICU) (OTCQX: MGMNF) (FSE: 8YD) (“Magna” or the “Company”) is pleased to announce that further to its news release dated November 18,

Brown & Brown, Inc. announces 2025 fourth-quarter earnings release and conference call dates

Brown & Brown, Inc. announces 2025 fourth-quarter earnings release and conference call dates GlobeNewswire December 31, 2025 DAYTONA BEACH, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE: BRO) announces it will release its 2025 fourth-quarter earnings on Monday, January 26, 2026, after the close of the market. On Tuesday, January 27,

Scroll to Top